Subscribe to Bioscience Technology Articles

The Lead

50 Years Later, Consortium Looks for Freeze-drying Overhaul

November 19, 2015 | by Bevin Fletcher, Associate Editor | Comments

Lyophilization, also known as freeze-drying, is a critical technology for the food industry, pharmaceuticals and biotech. However, the process, which removes water from products at low temperatures and low pressure, is expensive, time-consuming and has remained unchanged for the last 50 years. 

View Sample

FREE Email Newsletter Bioscience Technology Daily

Chelsea, Hillary, and Top Researchers Make Global Push For Girls In Science

November 24, 2015 9:22 am | by Cynthia Fox, Science Writer | Comments

 For an intense global program called 1000 Girls-1000 Futures, the NYAS recently sought 60 women willing to devote a full year to mentees from Mexico alone. NYAS head Ellis Rubenstein told the presser Mexican supporters were “terrified” no one would step up. But 170 woman researchers—and counting— stepped up worldwide.  


Optimizing ELISA

November 5, 2015 8:59 am | by Rishi Porecha, Ph.D. | Comments

ELISA – Enzyme-Linked Immunosorbent Assay – is a commonly used biochemical technique for the evaluation of an antigen or antibody in a sample. This technique is used in a wide range of applications, including: clinical diagnostics, plant pathology, the detection of food allergens and drug screening.


Direct-to-Patient Registries: A New Approach to Pharmacovigilance

October 28, 2015 9:38 am | by Nancy Dreyer, MPH, Ph.D., Global Chief of Scientific Affairs and Michelle Leavy, MPH, Manager, Health Policy, Quintiles | Comments

Understanding drug safety is a tricky thing. The use of direct-to-patient (or consumer) registry data is a new approach, and one that is quite different from the highly controlled world of clinical trials. Some worry about whether patients will be accurate and honest reporters. Will these patients be reliable, and will they provide clinically generalizable information?


Role Found for Critical Gene in 95% of ALS

October 22, 2015 9:10 am | by Cynthia Fox, Science Writer | Comments

Like a bad teenager, in 95 percent of all amyotrophic lateral sclerosis (ALS) cases, a protein called TDP-43 leaves its home— the nucleus of motor neuron cells—to congregate, in suspect fashion, in the cytoplasm. In a study published in Science this summer, the Johns Hopkins University (JHU) team of pathologist Phillip Wong, Ph.D., offered new insight into this molecular rebellion.


Some Stem Cells Are Rejected, Some Aren’t, Says iPSC Work

October 21, 2015 9:38 am | by Cynthia Fox, Science Writer | Comments

Embryonic stem (ES) cell-like stem cells made from adult cells—and morphed into eye cells—are not rejected by the immune system, according to “humanized mouse” data in Cell Stem Cell.


How to Make Your Surface Plasmon Resonance Experiments Successful

October 14, 2015 8:56 am | by Mary M. Murphy, Ph.D., Applications Scientist, Reichert Life Sciences | Comments

The technique of Surface Plasmon Resonance (SPR), allows scientists to monitor biomolecular binding interactions label-free, in real-time and using automation. For those of you thinking about, or planning on, using SPR, this article offers insights on how to use the technique successfully, gained from working with this technique for a number of years.


A Look at Landmark NIH Study on Substance Use and the Developing Brain

October 8, 2015 9:21 am | by Bevin Fletcher, Associate Editor | Comments

The National Institutes of Health has awarded 13 grants for a landmark, multi-site study that will follow 10,000 children over 10 years to observe how substance use affects the brain, and the findings could help guide important public policy decisions.


Johns Hopkins Women and Men Score Equal Numbers of Key NIH Grants

October 2, 2015 9:27 am | by Cynthia Fox, Science Writer | Comments

Young female and male Johns Hopkins University (JHU) Medical School M.D.’s and Ph.D.’s receive equal numbers of key National Institutes of Health (NIH) grants, says a recent Journal of Women’s Health study.


FDA Warns Startup Selling Suspicious Blood-Based Cancer Tests

October 1, 2015 8:26 am | by Ryan Bushey, Associate Editor | Comments

The agency wants more insight into the company's data and marketing materials supporting the effectiveness of their product.


Data Driven Research and the Next Generation of Informatics

September 30, 2015 8:41 am | by Tim Hoctor, Vice President Professional Services, Elsevier R&D Solutions | Comments

The wave of new and emerging technologies is significantly impacting the data capabilities and utilization of data in life sciences and drug development research. With the increasing public popularity of wearable devices and mobile health applications, coupled with growth in the use of social media, more data streams are available to researchers looking to extract meaningful information.


The Race to the Cloud - Changes Afoot for Life Science Research

September 24, 2015 8:39 am | by Merrilyn Datta, Ph.D., President and General Manager, Definiens | Comments

Storing health data in the cloud is predicted to be an industry worth $1 billion by 2018.


Q&A With Progressive Institute Leader Doug Hilton

September 22, 2015 9:29 am | by Cynthia Fox, Science Writer | Comments

Doug Hilton, Ph.D., is head of the Walter and Eliza Hall Institute of Medical Research, Australia’s oldest research institute. He has launched innovative gender-gap initiatives many scientists say far outpace those in the US. He wrote about it in Nature, and scientists reacted in Bioscience Technology. He responds here.


New Nanoparticles Clean the Environment, Drinking Water

September 18, 2015 8:45 am | by Bevin Fletcher, Associate Editor | Comments

Nanoparticles are between 1 and 100 nanometers in size.Scientists can harness them for drug delivery, to combat disease, for filtering fresh drinking water, and much more. Now, researchers from MIT and the Federal University of Goias in Brazil have developed a new technique that uses ultraviolet (UV) light to extract man-made pollutants from soil and water.


Three “Remarkable” Studies Say Clogged Pores May Cause ALS; Drug Targets ID’d

September 17, 2015 8:35 am | by Cynthia Fox, Science Writer | Comments

Three studies, analyzing in different ways the leading ALS gene, came to what is being called a “remarkably” similar conclusion: the most common form of ALS may be caused by clogged pores in brain cell nuclear membranes.


At 50, Each Body Mass Index Unit Increase Hastens Alzheimer’s 6.7 Months

September 4, 2015 11:34 am | by Cynthia Fox, Science Writer | Comments

A new Molecular Psychiatry study has found a robust relationship between obesity at age 50—as measured by body mass index (BMI)—and both earlier age, and severity, of Alzheimer’s disease (AD).



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.